Trima

Milky joined Trimas board of directors in 2014 and serves as the Companys chairman since 2018. Milky also serves as a board member in various publicly trade and private companies including Clal Bio Technologies, Exalenz BioSicence, Medison Biotech, Univo Pharmaceuticals, and Tiltan Pharma (Chairman of the Board). He also serves as a consultant to B... DO and Sol-Gel Pharma. Milky held the position of the CEO of Taro Pharmaceuticals Industries Ltd. for over 20 years. Under His leadership, Taro became a public company trading on TASE and NASDAQ. During his time in Taro, the company turned into a multinational company with over 1000 employees worldwide and a turnover of $450 million. On 2003, Milky received the Exceptional Industry Award from the Manufacturers Association of Israel. Milky joined Trimas board of directors in 2014 and serves as the Companys chairman since 2018. Milky also serves as a board member in various publicly trade and private companies including Clal Bio Technologies, Exalenz BioSicence, Medison Biotech, Univo Pharmaceuticals, and Tiltan Pharma (Chairman of the Board). He also serves as a consultant to BDO and Sol-Gel Pharma. Milky held the position of the CEO of Taro Pharmaceuticals Industries Ltd. for over 20 years. Under His leadership, Taro became a public company trading on TASE and NASDAQ. During his time in Taro, the company turned into a multinational company with over 1000 employees worldwide and a turnover of $450 million. On 2003, Milky received the Exceptional Industry Award from the Manufacturers Association of Israel. Ran became Chief Executive officer of TRIMA on January 1, 2019. Ran has more than 15 years experience in the Pharmaceutical and Biotech industries, filling various senior leadership positions across a range of markets and disciplines. Prior to joining TRIMA Ran held the position of CEO and Chairman of the Board of Tiltan Pharma, CEO of TCD Pharma, CEO and Member of the Board of Amadix, Business Development Director in CRB (an early stage VC) and Strategic Alliance ...Read More